Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sembiosys Genetics Inc. SBIYF

"SemBioSys Genetics Inc is engaged in developing high-value proteins and oils in plant seeds using its unique proprietary genetic expression and manufacturing technology platforms. The Company has operations in United States and Canada."


GREY:SBIYF - Post by User

Comment by RE38on Feb 02, 2012 2:45pm
143 Views
Post# 19481424

RE: RE: RE: RE: The same garbage happened with EKG

RE: RE: RE: RE: The same garbage happened with EKG

The deal was not done in Oct. It was pending government approval, which is the biggest hurdle to overcome when you're in the business of getting human beings to injest your product. I see you on the EKG board often so you should know EKG's price increase was on FDA approval, not on the fact the product design was complete several months ago. When NASDAQ biotech stocks submit to the FDA, there's a small pop on that news and a large pop on approval. Same thing here. Maybe it's not as difficult to get Chinese government approval as it is US, but its still a noteworthy milestone.

<< Previous
Bullboard Posts
Next >>